Treatment of attention deficit and hyperactivity disorder;Tratamiento del trastorno por déficit de atención con hiperactividad

Revista de Neurologia

Volumn 33, Issue 3, 2001, Pages 210-215

  Tuchman, R F ^a  

^a Dan Marino Center   (United States)

Author keywords

Attention deficit and hyperactivity disorder; Stimulant medication; Treatmemt

Indexed keywords

AMFEBUTAMONE; AMPHETAMINE; CENTRAL STIMULANT AGENT; CLONIDINE; DEXAMPHETAMINE; METHYLPHENIDATE; PEMOLINE MAGNESIUM; TRICYCLIC ANTIDEPRESSANT AGENT;

ATTENTION DEFICIT DISORDER; CHILD; CHILD CARE; CLINICAL PRACTICE; CONFERENCE PAPER; DOCTOR PATIENT RELATION; HUMAN; PHYSICIAN ATTITUDE; SYMPTOMATOLOGY;

EID: 0035415504     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3303.2001535     Document Type: Conference Paper

References (47)

1. National trends in the prevalence of attention-deficit/hyperactivity disorder and the prescribing of methylphenidate among school-age children: 1990-1995
2. Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder
3. Alternative (nonstimulant) medications in the treatment of attention-deficit/hyperactivity disorder in children
4. Management of stimulant medications in children with attention-deficit/hyperactivity disorder
5. Are stimulants overprescribed? Treatment of ADHD in four US communities
6. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle
7. Attention-deficit/hyperactivity disorder
8. Stimulant medications
9. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism
10. How stimulant drugs may calm hyperactivity
11. Dopamine D4 receptors: Significance for molecular psychiatry at the millennium
12. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder
13. Attention deficit/hyperactivity disorder
14. Analog classroom assessment of Adderall in children with ADHD
15. Objective and subjective measures of the pharmacodynamic effects of Adderall in the treatment of children with ADHD in a controlled laboratory classroom setting
16. A comparison of morning-only and morning/late afternoon Adderall to morning-only, twice-daily, and three times-daily methylphenidate in children with attention-deficit/hyperactivity disorder
17. A comparison of ritalin and Adderall: Efficacy and time-course in children with attention-deficit/hyperactivity disorder
18. Rating scales in attention-deficit/hyperactivity disorder: Use in assessment and treatment monitoring
19. Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial
20. Growth deficits in children with attention deficit hyperactivity disorder
21. Response to growth hormone in attention deficit hyperactivity disorder: Effects of methylphenidate and pemoline therapy
22. Lack of effect of methylphenidate on serum growth hormone (GH), GH-binding protein, and insulin-like growth factor I
23. Pemoline-associated hepatic failure: A critical analysis of the literature
24. Pemoline therapy resulting in liver transplantation
25. Adverse drug reaction. Pemoline and dyskinesia
26. Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder
27. Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD
28. Epilepsy and attention deficit hyperactivity disorder: Is methylphenidate safe and effective?
29. Attention-deficit hyperactivity disorder. Pharmacotherapy and beyond
30. Tricyclic antidepressant treatment of children with ADHD and tic disorders
31. Antidepressants in the treatment of attention-deficit/hyperactivity disorder
32. Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder
33. Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette's syndrome
34. A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder
35. Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders
36. Case study: Accidental clonidine patch over-dose in attention-deficit/hyperactivity disorder patients
37. Combining methylphenidate and clonidine: A clinically sound medication option
38. Guanfacine use in children with attention deficit hyperactivity disorder
39. Problems in the management of attention- deficit- hyperactivity disorder
40. Utilization of alternative therapies in attention-deficit hyperactivity disorder
41. Alternative and controversial treatments for attention-deficit/hyperactivity disorder
42. Effect of nutritional supplements on attentional-deficit hyperactivity disorder
43. The role of diet and behavior in childhood
44. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Multimodal Treatment Study of Children with ADHD
45. Moderators mediators of treatment response for children with attention-deficit/hyperactivity disorder: The Multimodal Treatment Study of children with attention-deficit/hyperactivity disorder
46. Assessment and intervention for attention-deficit/hyperactivity disorder in the schools. Lessons from the MTA study